CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global life sciences market, announced today that Jiangsu Provincial Institute of Materia Medica (JPIMM), has purchased the Provantis® preclinical SaaS solution suite to manage preclinical processes at its research facility in Nanjing.
JPIMM, part of Nanjing Tech University, conducts a wide range of study types including general toxicology, reproductive toxicology, genetic toxicology and carcinogenic studies. The institute, one of the first laboratories in China to be awarded GLP certification, has won more than 50 research awards and obtained 34 patents for inventions.
Provantis will replace JPIMM’s existing manual processes to deliver increased efficiencies in the collection, storage and reporting of preclinical data, as well as delivering further improvements in data quality and traceability.
- JPIMM to deploy an extensive suite of modules including General Toxicology, Pathology, Clinical Pathology, and Tables & Statistics
- JPIMM to access Provantis via the SaaS delivery model, benefiting from a reduced IT footprint and lower support costs, together with the flexibility and scalability to support further growth on-demand
- Contract awarded following a detailed competitive evaluation; Provantis recognized as the global market leader and the gold standard within China
- JPIMM has also purchased a range of professional services to facilitate quick implementation and a rapid return on investment
Dr. Jing Liu, Deputy Director of Jiangsu Provincial Institute of Materia Medica and Director of Jiangsu Center for Safety Evaluation of Drugs said “During our search for a preclinical data management solution it was vital for us to choose not only a proven, robust and comprehensive product, but also a vendor with the knowledge, experience and capabilities to support our future growth and our aspirations to increase our client base internationally. As the global market leader and the gold standard within China, we are confident that Instem and Provantis can help us achieve these goals.”
Jon Sparkes, Senior Director Sales, Europe & Asia, Instem, commented, “We are delighted to welcome JPIMM as our newest client within China and look forward to developing a long and fruitful relationship with them. We are particularly excited to see JPIMM join our growing roster of SaaS clients that have secure and immediate access to the latest versions of our products over the Web.”
Instem has an established full-service office in Shanghai and supports organizations through traditional on-site deployment , as well as through its SaaS delivery model from a secure, professionally managed data center based in Shanghai.
About Jiangsu Provincial Institute of Materia Medica (JPIMM)
JPIMM, part of Nanjing Tech University, consists of four professional research offices (the medical chemistry research office, the natural drug research office, the pharmacology and toxicity research office, and the pharmaceutical preparation and quality research room) as well as an experimental animal quality check station. JPIMM was one of the first laboratories in China to achieve GLP accreditation.
JPIMM has won more than 50 research awards (1 international award, 5 national awards, 26 provincial-level and ministry-level awards) and has obtained 34 patents for inventions. The institute has conducted academic exchanges with the USA, the UK, France, Japan and some South-east Asian countries and established research partnerships with WTO, IOCD, TAMU Institute of Ophthalmology and Pharmacology, US Bausch & Lomb, and HK Fugao Pharmaceutical Co. Ltd.
For further information visit http://jsyws.njtech.edu.cn/
Instem is a global provider of leading software solutions and services that are helping over 500 clients bring their life enhancing products to market faster. We enable clients in the life sciences to more efficiently collect, analyze, report and submit high quality regulatory data, while maintaining compliance for their products around the world.
Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making, leading to safer, more effective products.
Instem supports its global roster of clients through offices in the United States, United Kingdom, France, Japan, China and India.
For further information visit www.instem.com